S4482 | Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry | Smith & Moses
Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry
2019-2020 SessionPete HarckhamAffects: Public Health Law
Status
In Senate Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate
Bill Progress
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
What's Happening
Why It Matters
Waiting for summary...
Get alerts when S4482 moves
Create a free account to track this bill and get emailed when its status changes — committee votes, floor action, signing, or veto.